Topical Ocular Hypotensive Medication to Delay or Prevent the Onset of Primary Open-Angle Glaucoma
2020 ◽
pp. 85-90
Keyword(s):
The Ocular Hypertension Treatment Study (OHTS) was a randomized, open, placebo-controlled, clinical trial to determine whether reducing intraocular pressure (IOP) in eyes with ocular hypertension (OHTN) reduced the risk of developing primary open-angle glaucoma (POAG). The study found that topical ocular hypotensive medication was effective in delaying or preventing the development of glaucomatous optic neuropathy in eyes with OHTN. However, the authors recommended stratifying risk in patients with OHTN using variables such as baseline age, vertical and horizontal cup-to-disc ratio, visual field pattern standard deviation, IOP, and, especially, central corneal thickness.
2008 ◽
Vol 39
(1)
◽
pp. 17-21
◽
2001 ◽
Vol 85
(7)
◽
pp. 792-795
◽
1982 ◽
Vol 94
(5)
◽
pp. 610-616
◽
2002 ◽
Vol 80
◽
pp. 49-49
◽
2005 ◽
Vol 15
(3)
◽
pp. 324-328
◽
2021 ◽
Vol 8
(33)
◽
pp. 3084-3089
2017 ◽
Vol 05
(02)
◽
pp. 17497-17501